PIC Therapeutics (“PIC”), a biotechnology company focused on transforming the treatment of cancer though the selective modulation of oncogene translation, today announced the appointment of Katherine Bowdish, Ph.D., as its President and Chief Executive Officer. Dr. Bowdish will also join the Board of Directors of PIC. Dr. Bowdish brings more than 20 years of biopharmaceutical business and scientific leadership to PIC
August 12, 2020
· 3 min read